Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Kas Dan Setara
Keuangan
Harga Saham
USD
Aktiva
USD 12.05B
Kas Dan Setara
USD 1.02B
Biaya Penjualan
USD 312.82M
Aset Lancar
USD 2.3B
Kewajiban Lancar
USD 1.28B
UTANG
USD 3.35B
Dividen - Hasil
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
Karyawan
11K
Eps Laba Per Saham
USD 1.41
Modal Dan Cadangan
USD 7.18B
Laba Kotor Pada Penjualan
USD 416.87M
Beban Bunga Utang
USD 22.99M
Pendapatan Bunga
USD 6.3M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 15.86B
Batas Pemasukan
USD 51.82M
Biaya Operasional
USD 603.55M
Laba Operasional
USD 126.14M
Modal Saham Biasa
USD 111.63M
Pe Harga Untuk Laba
36.47
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729.68M
Beban Penjualan Dan Administrasi
USD 278.58M
Saham
USD 378.5M
Kreditur Perdagangan
USD 165.74M
Debitur Perdagangan
USD 709.18M
Kas Dan Setara
Perubahan
Tanggal
Agilent
USD 1.76B
49M
2026-06
Align Technology
USD 1.1B
42.76M
2026-06
Bio Techne
USD 264.71M
54.89M
2026-06
Bio-Rad Laboratories
USD 517M
9.8M
2026-06
Bruker
USD 184.9M
51.5M
2026-06
Celltrion
KRW 56.79B
6.92B
2026-03
Charles River Laboratories
USD 192.02M
195K
2026-06
Cspc Pharmaceutical
CNY 6.09B
1.48B
2025-12
Danaher
USD 4.35B
1.35B
2026-06
Dentsply International
USD 239M
49M
2026-06
Deva Holding AS
TRY 775.92M
574.67M
2023-09
Dianthus Therapeutics
USD 110.55M
517.12M
2026-06
Divis Laboratories Ltd
INR 1.28B
2.87B
2026-03
Edwards Lifesciences
USD 2.9B
500M
2026-06
Illumina
USD 1.09B
329M
2026-03
Intuitive Surgical
USD 8.63B
646.3M
2026-06
IQVIA Holdings
USD 1.91B
38M
2026-06
Kangmei Pharma
CNY 1.23B
48.16M
2026-03
Knight Therapeutics
CAD 76.45M
5.43M
2025-12
Laboratorios Farma
EUR 46.11M
18.92M
2025-06
Laboratory Of America
USD 141.8M
839.3M
2026-06
Malin Corporation
EUR 62.1M
26.4M
2024-12
Medical Developments International
AUD 17.84M
219K
2025-06
Mesa Laboratories
USD 28.98M
8.55M
2025-12
Mettler Toledo International
USD 51.38M
9.19M
2026-06
Myriad Genetics
USD 115.2M
9.2M
2026-06
Neuren Pharmaceuticals
AUD 4.23M
1.68M
2025-12
OraSure Technologies
USD 160.58M
16.38M
2026-06
Organigram Holdings
CAD 4.29M
3.28M
2026-03
Pacific Biosciences Of California
USD 61M
4.73M
2026-06
Pharma Mar
EUR 19.34M
29.53M
2026-06
Qiagen NV
USD 646.29M
192.72M
2026-03
Quest Diagnostics
USD 626M
233M
2026-06
Quidel
USD 123.4M
17M
2026-06
Repligen
USD 606.78M
24.13M
2026-06
Revvity
USD 1.02B
162.62M
2026-06
Sartorius
EUR 291M
282.8M
2026-06
Sino Biopharmaceutical
CNY 3.38B
2.09B
2024-12
Thermo Fisher Scientific
USD 3.25B
6.6B
2026-03
Tilray
USD 264.83M
43.16M
2025-06
Waters
USD 539M
77M
2026-06
Zealand Pharma A/S
3.85B
727.54M
2026-03
Zz Pientze Pharmaceu
CNY 1.96B
186.63M
2026-03
×